Annexin A9 antibody (AA 261-345)
Quick Overview for Annexin A9 antibody (AA 261-345) (ABIN759776)
Target
See all Annexin A9 (ANXA9) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 261-345
-
Purpose
- Annexin A9 Polyclonal Antibody
-
Predicted Reactivity
- Human,Mouse,Rat,Dog,Cow,Pig,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Annexin A9
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(1:300-5000),
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- Annexin A9 (ANXA9)
-
Alternative Name
- Annexin A9
-
Background
-
Synonyms: annexin 31, annexin A9, annexin XXXI, ANX31, ANXA9, ANXA 9, ANXA-9, pemphaxin, ANXA9_HUMAN .
Background: ANXA9 may act as a low affinity receptor for acetylcholine and is expressed in the stratified squamous skin epithelium, but not in epithelia of other types (at protein level). ANXA9 is one of the target molecules recognized by auto in patients with pemphigus vulgaris, a rare, autoimmune skin disease in which epidermal blisters occur as the result of the loss of cell-cell adhesion.
-
Gene ID
- 8416
Target
-